Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000254416 | SCV000301534 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
ARUP Laboratories, |
RCV000999733 | SCV000602403 | benign | Telangiectasia, hereditary hemorrhagic, type 2 | 2023-11-29 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000833921 | SCV000975689 | benign | not provided | 2018-06-16 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Genome- |
RCV000999733 | SCV002524606 | benign | Telangiectasia, hereditary hemorrhagic, type 2 | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000833921 | SCV005213145 | likely benign | not provided | criteria provided, single submitter | not provided |